Statement of Changes in Beneficial Ownership (4)
2019年9月12日 - 6:45AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
FELDER MITCHELL S |
2. Issuer Name and Ticker or Trading Symbol
PREMIER BIOMEDICAL INC
[
BIEI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__X__ Director __X__ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chairman of the Board
|
(Last)
(First)
(Middle)
P.O. BOX 25 |
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/11/2019
|
(Street)
JACKSON CENTER, PA 16133
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security (Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code (Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
9/11/2019
|
|
P
|
|
300000
|
A
|
$0.008
|
1628031
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
100000
|
A
|
$0.0082
|
1728031
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
250000
|
A
|
$0.0082
|
1978031
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
30250
|
A
|
$0.0082
|
2008281
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
1207
|
A
|
$0.0085
|
2009488
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
100000
|
A
|
$0.009
|
2109488
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
156892
|
A
|
$0.0095
|
2266380
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
40000
|
A
|
$0.0095
|
2306380
|
D
|
|
Common Stock
|
9/11/2019
|
|
P
|
|
28108
|
A
|
$0.0095
|
2334488
|
D
|
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code (Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)
|
8. Price of Derivative Security (Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
FELDER MITCHELL S P.O. BOX 25 JACKSON CENTER, PA 16133
|
X
|
X
|
Chairman of the Board
|
|
Signatures
|
/s/ Dr. Mitchell S. Felder
|
|
9/11/2019
|
**Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person, see Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Premier Biomedical (PK) (USOTC:BIEI)
過去 株価チャート
から 11 2024 まで 12 2024
Premier Biomedical (PK) (USOTC:BIEI)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Premier Biomedical Inc (PK) (その他OTC): 0 recent articles
その他のPremier Biomedical Incニュース記事
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。